Navigation Links
ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
Date:10/6/2010

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced positive preliminary results from a Phase 1/2 clinical study of bepotastine besilate nasal spray conducted in Canada for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The findings demonstrated two of the three bepotastine besilate concentrations tested were effective in relieving patients' nasal symptoms after exposure to seasonal allergens. The safety data showed the drug to be well-tolerated, with adverse events consistent with those observed with other antihistamine nasal sprays and generally rated as mild. As a result of the positive outcomes, ISTA plans to submit an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration (FDA) and to initiate Phase 2 clinical studies of bepotastine besilate nasal spray before the end of 2010.

Commenting on the results of the study, Timothy R. McNamara, Pharm.D., Vice President of Clinical Research and Medical Affairs of ISTA Pharmaceuticals, said, "During the clinical trials for BEPREVE®, our twice-daily prescription eye drop for ocular itching associated with allergic conjunctivitis, patients noted improvement in nasal symptoms. The Phase 1/2 study data with bepotastine besilate nasal sprays supports our initial findings with the BEPREVE ophthalmic solution on the efficacy of bepotastine for the treatment of nasal symptoms.

"The results of our nasal bepotastine Phase 1/2 clinical study in Canada show a robust patient response to the nasal spray without serious side effects, giving us confidence to move forward into Phase 2 clinical trials.  We plan to file an IND application for bepotastine nasal spray and start a Phase 2 trial in Texas before year-end 2010, using one of the most potent seasonal allergy
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. MAP Pharmaceuticals Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
2. Savient Pharmaceuticals Announces Dismissal of Class Action Lawsuit
3. Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
4. Transcept Pharmaceuticals to Present at BIO Investor Forum
5. MAP Pharmaceuticals, Inc. Announces Pricing of Underwritten Registered Offering of Common Stock
6. Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management
7. Prolong Pharmaceuticals Names Industry Veteran Glenn Kazo President
8. Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
9. Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
10. Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
11. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Unichem Pharmaceuticals ( ... one lot of Hydrochlorothiazide tablets 25 mg 1000-count bottle ... as a precautionary measure due to the identification of ... product. The risk associated with mistakenly ... is the increased probability of experiencing Clopidogrel,s side effects ...
(Date:7/30/2015)... 30, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the patented biopharmaceutical, modernized traditional Chinese medicine ... updates regarding the notice it received on May 21, ... that the Company was below certain of the Exchange,s ... and 1101 of the NYSE MKT Company Guide, due ...
(Date:7/30/2015)... July 30, 2015 ... report with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... Insight: Biosensors Market Development and Demand Forecast ... http://photos.prnewswire.com/prnh/20150727/756778 ) Explore more about ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced ... (MAA) with the European Medicines Agency (EMA) for lorcaserin, ... weight loss and maintenance of weight loss, in patients ... overweight (BMI >27) and have at least one weight-related ...
... Corporation (NASDAQ: IRIX ) today announced that ... conferences this month. The Company presents today ... Conference where President and CEO Dominik Beck will host ... the day.  The Company is also ...
Cached Medicine Technology:Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control 2Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control 3Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control 4
(Date:7/31/2015)... ... 2015 , ... “ Crack’em ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... , Cooking can be a very messy experience, especially when cracking eggs. Cracking an ...
(Date:7/31/2015)... ... July 31, 2015 , ... Nutritional Products International, ... nutritional and wellness products, announced the addition of Vincent Aquilino to its Board ... isolated stretching and the prevention and rehabilitation of injuries, has spent the last ...
(Date:7/31/2015)... ... July 31, 2015 , ... Intellitec Solutions ... recent implementation of Microsoft Dynamics GP for a senior living facility in Maine. ... supporting senior living communities in 16 states. This further expansion was again a ...
(Date:7/31/2015)... ... July 31, 2015 , ... With the ... number of individuals who remain undiagnosed, treatment options for patients are becoming more ... traditional CPAP therapy due to its overall lack of comfort and highly invasive ...
(Date:7/30/2015)... ... July 31, 2015 , ... Reduce Human Error on the ... FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, 2015 – Raleigh, NC, ... biologic and device firms reduce manufacturing errors by 50 percent or more, will ...
Breaking Medicine News(10 mins):Health News:Make Less Mess while Cooking with Crack’em 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4
... be entangled in a health controversy now in China. Scientists ... causing agent, in potato fries exceeds the limit in drinking ... times.// ,The Chinese Ministry of Health said that measures ... acrylamide in humans. ,In April, the Chinese Ministry of ...
... reduce men's deaths from heart disease - even when ... above finding holds good regardless of the cholesterol level ... risk of dying from cardiovascular disease if they are ... effect relationship with respect to cardiovascular disease discovered that ...
... have published the results of their work linking mutations in ... was published in the Journal of Medical Ethics. //Mutations in ... and ovarian cancer in women has now found to increase ... men. The results of the study also confirmed the relation ...
... women confirms previous studies showing that a high-protein diet ... high carbohydrate diet. Researchers have also demonstrated that when ... protein-rich diet is still more effective at reducing body ... interactive effect when a protein-rich diet is combined with ...
... obesity is severe like never before. The problem seems to ... from Tufts University this month proves, when it comes to ... ,''It's quite astounding -- this shows that we can't afford ... specialist involved with the initiative that brought the girls to ...
... had discovered that a single molecule is responsible for ... body. // ,By blocking the molecule’s anchoring ... to stave off the most common serious infection of ... childhood death and disability. The researchers’ findings appear in ...
Cached Medicine News:Health News:French Fries In Cancer Controversy In China 2Health News:A Protein-Rich Diet Combined With Exercise Found To Be More Effective In Weight Loss 2Health News:Early Awareness About Weight Management Needed To Tackle Lifelong Obesity 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: